Nifty Pharma Today: Index Down 0.20% in Early Trade

Updated: 4 Sept 2026 • 10:05 am

Posted by:

Nifty Pharma Today: Index Down 0.20% in Early Trade

Quick sector takeaways

Nifty Pharma was down 0.20%, or 54.20 points, at 26,604.45 in the early session on 4 September 2026.
The index was below its previous close of 26,658.65 after trading between 26,504.90 and 26,695.00 during the session so far.
Market breadth was negative: 15 of 20 displayed stocks declined, while five advanced and none were unchanged.
JB Chemicals & Pharmaceuticals, Ajanta Pharma and Alkem Laboratories led the declines, while Aurobindo Pharma, Dr. Reddy’s Laboratories and Biocon were among the gainers. Watch whether breadth improves through the session.

Nifty Pharma today: early-session update

Nifty Pharma today reflected a mildly weak opening-bell tone, with the index at 26,604.45, down 54.20 points or 0.20% from the previous close of 26,658.65. The move places the index below both its prior close and opening level of 26,659.55 as of 10:00:00 AM IST.

The decline is modest at the index level, but the stock-level picture is broader: three-fourths of the displayed pharma shares were in the red. This indicates that the early pressure was spread across the sector rather than being restricted to one or two names. At the same time, a group of gainers within the index kept the overall fall contained.

For readers tracking the sector through the day, the key facts are the index’s position relative to its opening level, the intraday range and whether the advance-decline balance begins to narrow. The current reading remains an early-session snapshot rather than a full-day outcome.

Price snapshot

Metric	Level	Early-session reading
Last traded price	26,604.45	Down 54.20 points
Previous close	26,658.65	Reference level for the day
Day high	26,695.00	Above the previous close
Day low	26,504.90	Below the opening level

The index opened at 26,659.55, close to the previous close, climbed to 26,695.00 and later moved down to 26,504.90. Its last traded level of 26,604.45 was 90.55 points above the day low and 90.55 points below the day high, placing it at the midpoint of the session’s range so far. This is an observation on the early intraday range, not a directional forecast.

Sector ranking

Nifty Pharma was the second top losing sector index among the configured sector indices at this reading. Nifty FMCG was lower by 0.22%, while Nifty Pharma followed with a 0.20% fall. Nifty Auto was marginally lower by 0.02%, whereas several other tracked sector indices were positive.

This ranking provides useful context for the sector’s early movement. The decline in pharma was not the deepest among the tracked indices, but it was sufficiently broad to place the group near the weaker end of the sector board. The ranking may change as prices update through the trading day.

Constituent breadth

Of the 20 displayed Nifty Pharma stocks, 15 were decliners and five were advancers, with no stock unchanged. The advance-decline ratio stood at 0.33, meaning there was roughly one advancing stock for every three declining stocks.

That breadth profile is more negative than the index’s 0.20% decline alone may suggest. It shows that losses were distributed across a sizeable part of the index, even as advances in select shares moderated the aggregate move. Monitoring the count of gainers and losers alongside the index level can help distinguish a narrow move from a broader sector move.

Heavyweights versus broader participation

The supplied heavyweight set showed mixed but mostly negative participation. Sun Pharmaceutical Industries was down 0.36% at Rs 1,909.10, while Divi’s Laboratories fell 0.62% to Rs 9,192.50. Cipla declined 0.65% to Rs 1,385.60.

On the positive side, Torrent Pharmaceuticals gained 0.16% to Rs 4,913.50 and Dr. Reddy’s Laboratories rose 0.41% to Rs 1,159.70. The supplied active-stock watchlist includes these same key names, making their intraday direction relevant to the sector’s evolving tone. The mix of declines and gains among these stocks aligns with an index move that is negative but limited in magnitude.

Key Nifty Pharma stocks

Stock	Move	Why it matters
JB Chemicals & Pharmaceuticals	Rs 2,408.90, -3.87%	Largest percentage decliner among the displayed stocks.
Ajanta Pharma	Rs 3,474.80, -1.31%	One of the sharpest early declines in the sector.
Alkem Laboratories	Rs 5,140.50, -1.01%	Its fall added to the negative breadth.
Aurobindo Pharma	Rs 1,649.40, +0.74%	Top percentage gainer in the displayed group.
Dr. Reddy’s Laboratories	Rs 1,159.70, +0.41%	Provided positive counterweight within key names.

Biggest positive movers

Aurobindo Pharma led the gainers with a 0.74% rise to Rs 1,649.40 and was trading at its day high. Dr. Reddy’s Laboratories advanced 0.41%, Biocon gained 0.36%, Ipca Laboratories rose 0.30% and Torrent Pharmaceuticals added 0.16%.

The presence of five gainers shows that the sector was not uniformly weak. Aurobindo Pharma, Dr. Reddy’s Laboratories and Biocon were the strongest positive movers by percentage among the displayed stocks, while Ipca Laboratories and Torrent Pharmaceuticals also stayed above their previous closes.

Biggest negative movers

JB Chemicals & Pharmaceuticals was the largest loser, down 3.87% to Rs 2,408.90 after trading between Rs 2,380.00 and Rs 2,525.50. Ajanta Pharma fell 1.31% to Rs 3,474.80, while Alkem Laboratories declined 1.01% to Rs 5,140.50.

Zydus Lifesciences was lower by 0.89%, Glenmark Pharmaceuticals fell 0.78%, and Natco Pharma slipped 0.77%. These moves, alongside declines in other displayed constituents, shaped the sector’s negative breadth in early trade.

Stocks to watch next session

JB Chemicals & Pharmaceuticals: It was the largest percentage decliner and traded across a wide early-session range.
Aurobindo Pharma: It led the sector’s gainers and was at its day high at the reported level.
Ajanta Pharma: It was among the leading losers and traded close to its day low.
Divi’s Laboratories: The heavyweight was down 0.62% at Rs 9,192.50.
Dr. Reddy’s Laboratories: It was among the positive heavyweight names, up 0.41%.
Sun Pharmaceutical Industries: Its 0.36% decline keeps it relevant to the broader sector read.

The constructive case

The constructive evidence is the presence of five advancing stocks despite the negative sector print. Aurobindo Pharma’s 0.74% gain, followed by gains in Dr. Reddy’s Laboratories, Biocon, Ipca Laboratories and Torrent Pharmaceuticals, shows that buying interest remained visible in select pharma names.

The index also stood at the midpoint of its intraday range at the stated time, after recovering from the day low of 26,504.90. This early-session position, together with positive moves in some heavyweight names, kept the overall index decline at 0.20%.

The cautious case

The cautious case rests on breadth: 15 of 20 displayed stocks were lower. The leading declines in JB Chemicals & Pharmaceuticals, Ajanta Pharma and Alkem Laboratories were materially larger than the gains recorded by the top advancers.

The index also remained below its previous close and its opening level at 10:00:00 AM IST. Until the gainers-to-losers balance improves or the index moves back above these reference points, the early-session picture remains one of measured sector pressure.

Univest Insights

Nifty Pharma today presents a split early-session setup: the index decline is contained, but the breadth is decisively negative. That distinction matters because a small index move can coexist with wider stock-level weakness.

The heaviest pressure came from JB Chemicals & Pharmaceuticals, Ajanta Pharma and Alkem Laboratories, while Aurobindo Pharma and Dr. Reddy’s Laboratories offered visible offsets. Divi’s Laboratories, Sun Pharmaceutical Industries and Cipla were also lower, reinforcing the softer tone among several prominent names.

The intraday range of 26,504.90 to 26,695.00 gives traders a clear view of the session’s movement so far, without assigning a technical interpretation to either level. Readers can follow the sector’s live developments through Univest Market View.

For traders and investors, the key signal to watch is whether Nifty Pharma today can improve its breadth while holding closer to its previous close of 26,658.65.

Published on 4 September 2026 at 10:04 AM IST

Frequently asked questions

1. What is Nifty Pharma today?

Nifty Pharma was at 26,604.45, down 54.20 points or 0.20%, as of 10:00:00 AM IST on 4 September 2026.

2. What was the Nifty Pharma intraday range?

The index traded between a day low of 26,504.90 and a day high of 26,695.00.

3. How was Nifty Pharma breadth in early trade?

Among 20 displayed stocks, 15 declined and five advanced, while none were unchanged.

4. Which stock was the top gainer in Nifty Pharma?

Aurobindo Pharma was the top gainer among the displayed stocks, rising 0.74% to Rs 1,649.40.

5. Which stock was the biggest loser in Nifty Pharma?

JB Chemicals & Pharmaceuticals was the biggest loser among the displayed stocks, falling 3.87% to Rs 2,408.90.

6. Where can I track Nifty Pharma stocks?

You can track the sector and its displayed stocks on the Nifty Pharma screener on Univest.

Disclaimer

Investments in securities markets are subject to market risks. Read all related documents carefully before investing. This sector-index update is for informational and educational purposes only and is not personalized investment advice or a recommendation to buy, sell, or hold any security.